Literature DB >> 18692749

Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia.

Nicolas Fayed1, Jorge Dávila, Antonio Oliveros, Julio Castillo, Jaime J Medrano.   

Abstract

RATIONALE AND
OBJECTIVES: Mild cognitive impairment has been regarded as a pre-Alzheimer condition, but some patients do not develop dementia. The authors' objective was to determine whether findings from a combined use of H1 magnetic resonance spectroscopy (MRS), perfusion imaging (PI), and diffusion-weighted imaging (DWI) would predict conversion from amnesic mild cognitive impairment to dementia and to compare the diagnostic accuracy in discriminating patients with probable Alzheimer disease (AD), mixed dementia (MD), Lewy body dementia (LBD), pre-Alzheimer disease mild cognitive impairment (MCI), vascular MCI (VaMCI), and anxious or depression patients with cognitive impairment (DeMCI).
MATERIALS AND METHODS: A longitudinal cohort of 119 consecutive and incident subjects (73 women, 46 men; age 70+/-9.5 years) who fulfilled the criteria of amnesic MCI was followed for a mean period of 29 months. At baseline, a neuropsychological examination and standard blood test were performed, and different areas were examined by proton MRS, PI, and DWI. Among the group of patients considered to have AD, we also included patients with MD because these patients have a neurodegenerative component.
RESULTS: After the follow-up period, 54 patients were considered as converted to dementia (49 with AD; 5 with LBD), 28 patients as MCI, 22 patients as DeMCI, and 15 patients as VaMCI. We found that N-acetylaspartate (NAA)/creatine (Cr) ratios in posterior cingulated gyri (PCG) predict the conversion to probable AD with a sensitivity of 82% and specificity of 72%, and NAA/Cr ratios in the left occipital cortex (LOC) had a sensitivity of 78% and specificity of 69%. When we used spectroscopy in the PCG and LOC to differentiate the types of MCI and dementias, we found significance differences in NAA/Cr, NAA/myoinositol (mI), NAA/choline (Cho), mI/NAA, and Cho/Cr ratios. The apparent diffusion coefficient (ADC) values in the right hippocampus showed differences in patients with LBD and DeMCI (P=.003), LBD with MCI (P=0.48), and LBD and VaMCI (P=.009).
CONCLUSIONS: NAA/Cr ratios in PCG and LOC can predict the conversion from MCI to dementia with high sensitivity and specificity. MRS can differentiate AD from MCI, but cannot differentiate the types of MCI. DWI in the right hippocampus presents higher values of ADC in LBD and allows differentiating it from MCI.

Entities:  

Mesh:

Year:  2008        PMID: 18692749     DOI: 10.1016/j.acra.2008.04.008

Source DB:  PubMed          Journal:  Acad Radiol        ISSN: 1076-6332            Impact factor:   3.173


  21 in total

1.  [MR spectroscopy in dementia].

Authors:  T Hauser; L Gerigk; F Giesel; L Schuster; M Essig
Journal:  Radiologe       Date:  2010-09       Impact factor: 0.635

2.  Proton MR spectroscopy and white matter hyperintensities in idiopathic normal pressure hydrocephalus and other dementias.

Authors:  O Algin; B Hakyemez; M Parlak
Journal:  Br J Radiol       Date:  2010-07-20       Impact factor: 3.039

3.  [Mild cognitive impairment: diagnostic value of different MR techniques].

Authors:  T Hauser; P A Thomann; B Stieltjes; M Essig
Journal:  Radiologe       Date:  2011-04       Impact factor: 0.635

4.  Decreased Glutamate Levels in Patients with Amnestic Mild Cognitive Impairment: An sLASER Proton MR Spectroscopy and PiB-PET Study.

Authors:  Burcu Zeydan; Dinesh K Deelchand; Nirubol Tosakulwong; Timothy G Lesnick; Orhun H Kantarci; Mary M Machulda; David S Knopman; Val J Lowe; Clifford R Jack; Ronald C Petersen; Gülin Öz; Kejal Kantarci
Journal:  J Neuroimaging       Date:  2017-06-29       Impact factor: 2.486

5.  Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study.

Authors:  Zhong-Xian Yang; Shan-Shan Huo; Xiao-Fang Cheng; Zhi-Feng Xu; Zhen Cao; Jie-Xia Zeng; Ye-Yu Xiao; Ke-Zeng You; Wei Chen; Yan-Yan Liu; Ren-Hua Wu
Journal:  Neuroradiology       Date:  2011-07-08       Impact factor: 2.804

Review 6.  Various MRS application tools for Alzheimer disease and mild cognitive impairment.

Authors:  F Gao; P B Barker
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-17       Impact factor: 3.825

7.  Multiparametric magnetic resonance imaging of brain disorders.

Authors:  Ona Wu; Rick M Dijkhuizen; Alma Gregory Sorensen
Journal:  Top Magn Reson Imaging       Date:  2010-04

Review 8.  The role of diffusion tensor imaging in detecting microstructural changes in prodromal Alzheimer's disease.

Authors:  Bing Zhang; Yun Xu; Bin Zhu; Kejal Kantarci
Journal:  CNS Neurosci Ther       Date:  2013-12-12       Impact factor: 5.243

9.  Hippocampal blood flow in normal aging measured with arterial spin labeling at 3T.

Authors:  Henry Rusinek; Miroslaw Brys; Lidia Glodzik; Remigiusz Switalski; Wai-Hon Tsui; Francois Haas; Kellyanne McGorty; Qun Chen; Mony J de Leon
Journal:  Magn Reson Med       Date:  2011-01       Impact factor: 4.668

10.  MRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's disease.

Authors:  Bing Zhang; Tanis J Ferman; Bradley F Boeve; Glenn E Smith; Mandie Maroney-Smith; Anthony J Spychalla; David S Knopman; Clifford R Jack; Ronald C Petersen; Kejal Kantarci
Journal:  J Neuroimaging       Date:  2014-07-15       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.